Kerry McLaughlin
Overview
Explore the profile of Kerry McLaughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McLaughlin K, Konstantatos A, Karna S, Azzopardi S, Buckland M, Sivakumar H, et al.
Reg Anesth Pain Med
. 2024 Sep;
PMID: 39266223
Background: The value of epidural analgesia in pediatric patients having heart and lung transplant surgery is unknown. We aimed to characterize various quality outcomes in patients who did and did...
2.
Seneviratne U, McLaughlin K, Reilly J, Luckhoff C, Myles P
Emerg Med Australas
. 2023 Dec;
36(2):310-317.
PMID: 38054252
Objective: To ascertain and develop recommendations for analgesic management, discharge planning and further healthcare utilisation of adults presenting to an Australian tertiary ED with radicular or low back pain (LBP)....
3.
McLaughlin K, Acreman S, Nawaz S, Cutteridge J, Clark A, Knudsen J, et al.
Diabet Med
. 2022 Oct;
39(12):e14984.
PMID: 36264270
Background: Tetraspanin-7 (Tspan7) is an islet autoantigen involved in autoimmune type 1 diabetes and known to regulate β-cell L-type Ca channel activity. However, the role of Tspan7 in pancreatic β-cell...
4.
Katz N, Lloyd-Jones M, Demediuk L, McLaughlin K, McKechnie M, Gold M
J Patient Exp
. 2022 Feb;
9:23743735221079141.
PMID: 35174259
In Australia, high-dose sublingual buprenorphine and long-acting injectable buprenorphine are available. High-dose buprenorphine is used predominantly in the setting of opioid use disorder and has a role in chronic pain....
5.
McLaughlin K, Carr V, Iqbal M, Seago J, Lefevre E, Robinson L, et al.
Clin Vaccine Immunol
. 2010 Dec;
18(2):311-7.
PMID: 21147937
The use of heat shock proteins (HSP) to enhance activation of the immune response to chaperoned antigen is being explored for immunotherapy. Hsp110 chaperones large protein substrates more effectively than...
6.
McLaughlin K, Seago J, Robinson L, Kelly C, Charleston B
Vet Res
. 2010 Feb;
41(3):36.
PMID: 20167197
Foot-and-mouth disease virus (FMDV) is the causative agent of a highly contagious acute vesicular disease affecting cloven-hoofed animals, including cattle, sheep and pigs. The current vaccine induces a rapid humoral...
7.
Juleff N, Windsor M, Lefevre E, Gubbins S, Hamblin P, Reid E, et al.
J Virol
. 2009 Jan;
83(8):3626-36.
PMID: 19176618
The role of T-lymphocyte subsets in recovery from foot-and-mouth disease virus (FMDV) infection in calves was investigated by administering subset-specific monoclonal antibodies. The depletion of circulating CD4(+) or WC1(+) gammadelta...